Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.45 AUD | -0.41% | +1.66% | -15.22% |
Mar. 05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
Feb. 28 | Transcript : Australian Clinical Labs Limited, H1 2024 Earnings Call, Feb 28, 2024 |
Business Summary
Number of employees: 5,115
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pathology
97.2
%
| 977 | 98.1 % | 678 | 97.2 % | -30.60% |
Clinic
2.1
%
| 13 | 1.3 % | 14 | 2.1 % | +12.86% |
Other
0.6
%
| 6 | 0.6 % | 4 | 0.6 % | -27.59% |
Rental
0.1
%
| 1 | 0.1 % | 1 | 0.1 % | +34.88% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 996 | 100.0 % | 697 | 100.0 % | -29.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
James Davison
DFI | Director of Finance/CFO | - | 14-12-31 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Sean Jackson
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Anthony Friedli
COO | Chief Operating Officer | - | 15-12-31 |
Joe Geran
SAM | Sales & Marketing | - | 14-12-31 |
Eric Swayn
PRN | Corporate Officer/Principal | - | 14-12-31 |
Shae Seymour
PRN | Corporate Officer/Principal | - | 17-12-31 |
Chris Brownlow
PRN | Corporate Officer/Principal | - | 10-12-31 |
Eleanor Padman
SEC | Corporate Secretary | - | 21-04-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 14-12-31 |
Leanne Rowe
BRD | Director/Board Member | 67 | 21-04-27 |
Director/Board Member | - | 23-08-22 | |
Andrew Dutton
BRD | Director/Board Member | - | 21-04-27 |
Director/Board Member | - | 18-03-31 | |
Mark Haberlin
BRD | Director/Board Member | 61 | 21-04-27 |
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 201,834,015 | 112,579,972 ( 55.78 %) | 1,330,743 ( 0.6593 %) | 55.78 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HEALIUS LIMITED 4.99% | 36,230,451 | 4.99% | 31,318,689 $ |
2,318,243 | 1.15% | 4,068,424 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.22% | 322M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.59B | |
-12.71% | 16.73B | |
-2.32% | 16.36B | |
-2.63% | 14.92B | |
-31.58% | 11.77B | |
-0.61% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- ACL Stock
- Company Australian Clinical Labs Limited